Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides
- 22 May 2002
- journal article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 9 (11), 749-751
- https://doi.org/10.1038/sj.gt.3301758
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein–Barr virus (EBV)-based plasmid vectorsGene Therapy, 2001
- SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promotersGene Therapy, 2001
- Defective Lentiviral Vectors Are Efficiently Trafficked by HIV-1 and Inhibit Its ReplicationMolecular Therapy, 2001
- Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virusJournal of Antimicrobial Chemotherapy, 2001
- Erythrocyte‐mediated delivery of dexamethasone in patients with chronic obstructive pulmonary diseaseBiotechnology and Applied Biochemistry, 2001
- Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligandsNature Biotechnology, 2001
- Ligand-Receptor-Mediated Drug Delivery: An Emerging Paradigm in Cellular Drug TargetingCritical Reviews in Therapeutic Drug Carrier Systems, 2001
- A new acyclic heterodinucleotide active against Human Immunodeficiency Virus and Herpes Simplex VirusAntiviral Research, 2000
- Modulated red blood cell survival by membrane protein clusteringMolecular and Cellular Biochemistry, 1995
- Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies.Proceedings of the National Academy of Sciences of the United States of America, 1992